Cited by 1,220Healthcare Systems and ReformsGlobal Health Care IssuesGlobal Public Health Policies and Epidemiology

Global health 2035: a world converging within a generation

Open access
Jamison, Dean T, Summers, Lawrence H, Alleyne, George, Arrow, Kenneth J, Berkley, Seth, Binagwaho, Agnes, Bustreo, Flavia, Evans, David +17 more·2013·The Lancet

Abstract

countries can be reduced by 2035 through inexpensive population-based and clinical interventions.Fiscal policies are an especially promising lever for reducing this burden. Opportunities:• National governments can curb NCDs and raise signifi cant revenue by heavily taxing tobacco and other harmful substances, and they can redirect fi nances towards NCD control by reducing subsidies on items such as fossil fuels.Investment in strengthening health systems to deliver packages of costeff ective clinical interventions for NCDs and injuries is another important national opportunity.• International action should focus on provision of technical assistance on fi scal policies, regional cooperation on tobacco, and funding of population, policy, and implementation research on scaling-up of interventions for NCDs and injuries.Progressive universalism, a pathway to universal health coverage (UHC), is an effi cient way to achieve health and fi nancial protectionThe Commission endorses two pro-poor pathways to achieving UHC within a generation.In the fi rst, publicly fi nanced insurance would cover essential health-care interventions to achieve convergence and tackle NCDs and injuries.This pathway would directly benefi t the poor because they are disproportionately aff ected by these problems.The second pathway provides a larger benefi t package, funded through a range of fi nancing mechanisms, with poor people exempted from payments.Opportunities:• For national governments, progressive universalism would yield high health gains per dollar spent and poor people would gain the most in terms of health and fi nancial protection.• The international community can best support countries to implement progressive universal health coverage by fi nancing population, policy, and imple mentation research, such as on the mechanics of designing and implementing evolution of the benefi ts package as the resource envelope for public fi nance grows.Our report points to the possibility of achieving dramatic gains in global health by 2035 through a grand con vergence around infectious, child, and maternal mortality; major reductions in the incidence and consequences of NCDs and injuries; and the promise of universal health coverage.Good reasons exist to be optimistic about seeing the global health landscape utterly transformed in this way within our lifetimes.For the background papers see http://globalhealth2035.org Panel 2: Social and intersectoral determinants and consequences of better healthThree key WHO publications have advanced our understanding of these relations: • The 1999 World Health Report (WHR), the fi rst WHR issued by WHO Director General Gro Harlem Brundtland, estimated that half of the health improvements between 1960 and 1990 in low-income and middle-income countries were from changes in two social determinants: income and education.7 The report noted that these determinants aff ect health through consequences such as poor nutrition, sanitation, and other risk factors for ill health.Nevertheless, WHR 1999 argued that the health community could have the greatest eff ect on health by focusing on the health sector, including health systems strengthening, rather than by taking action outside this sector.• The 2001 report of the Commission on Macroeconomics and Health, chaired by Jeff rey Sachs, emphasised the importance of investment not only in the health sector but also in education, water, sanitation, and agriculture, to reduce poverty.8 By quantifying both the substantial economic consequences of better health and the costs of achieving it, the report had a hugely important role in informed advocacy for the health sector.• The Commission on Social Determinants of Health, chaired by Michael Marmot, was established by WHO in 2005 to lay out evidence for how to promote health equity through sound social and economic policies and to foster a global movement towards its achievement.9 The Commission made three broad recommendations: improve daily conditions; take "far-reaching and systematic action" to improve the distribution of resources to ensure "fair fi nancing, corporate social responsibility, gender equity and better governance"; and improve data collection for better measurement of health inequities and monitor the eff ect of interventions in improving these inequities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(13)62105-4

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies show that for every dollar spent on key health services, direct and indirect benefits exceed costs by a factor of 9 to 20.

    “Furthermore, studies show that for every dollar spent on key health services, the direct and indirect benefits would exceed costs by a factor of between 9 and 20, further showing the benefits that arise from investing in health.3”

    From The legal determinants of health: harnessing the power of law for global health and sustainable development (2019) · cites this paper as [3]

    The National opportunities and Costs and consequences of convergence sections report projected benefits exceeding costs by about 9-fold for low-income countries and about 20-fold for lower-middle-income countries. These are estimates for a specified scale-up of interventions toward convergence by 2035, conditional on targeting the right interventions and strengthening health systems—not a general return for every dollar spent on key health services. No page numbers were provided for these passages. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Law can implement fair, evidence-based health interventions and is a powerful instrument for global health.

    “Law can be used to implement fair, evidence-based health interventions, and can be a powerful tool for global health.3”

    From The legal determinants of health: harnessing the power of law for global health and sustainable development (2019) · cites this paper as [3]

    Section 3, “Stronger health systems and policies” (page unavailable), identifies laws and regulations as tools for tackling health risks. “Regulation and legislation” and “National opportunities” (pages unavailable) give evidence-backed examples, including drink-driving laws and pesticide restrictions. The paper does not establish that the interventions implemented through law are fair; its discussion of equity is separate from these legal measures. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Global health hazards have common underlying causes such as dangerous pathogens, unhealthy behaviours, or unsafe environments.

    “(ii) they have common underlying causes, such as dangerous pathogens, unhealthy behaviours, or unsafe environments;”
  • Global health hazards require a coordinated, multi-sectoral global response.

    “(iv) they require a coordinated, multi-sectoral global response.”
  • Global health hazards are exacerbated by inequities linked to socio-economic determinants of health.

    “(iii) they are exacerbated by inequities linked to the socio-economic determinants of health;”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

6 of the 174 references couldn’t be matched to a known paper.

Research works printed but not linked: 23

  1. [3]3. William Hsiao (Harvard University), Peter Hotez (Baylor College of Medicine, Houston, TX, USA), Prabhat Jha (University of Toronto, ON, Canada), Kjell Arne Johansson (University of Bergen), Gerald Keusch (Boston University, Boston, MA, USA), Daniel Kress (Bill & Melinda Gates Foundation), Ramanan Laxminarayan (Center for Disease Dynamics, Economics & Policy), Andrew Makaka (Ministry of Health, Rwanda), Robert Mansfi eld (University of California, San Francisco), Grant Miller (Stanford University, CA, USA), Suerie Moon (Harvard University), Dariush Mozaff arian (Brigham and Women's Hospital, Harvard University), Irina Nikolic (World Bank), Anders Nordström (Ministry of Foreign Aff airs, Sweden), Rachel Nugent (University of Washington), Ingvar Olsen (Norwegian Agency for Development Cooperation, Oslo, Norway), Miriam Rabkin (Columbia University, New York, NY, USA), John-Arne Røttingen (Norwegian Knowledge Centre for the Health Services, Oslo, Norway), Gloria Sangiwa (Management Sciences for Health, Cambridge, MA, USA), Thomas Schmid (Centers for Disease Control and Prevention), Jaime Sepulveda (University of California, San Francisco), Kirk Smith (University of California, Berkeley, CA, USA), Scott Stewart (United States Agency for International Development), Jonas Støre (Foreign Minister 2005-2012, and Health Minister from 2012 to October, 2013, Norway), Julia Watson (UK Department for International Development), Matthew Wright (Bank of Botswana, Gaborone, Botswana), Abdo Yazbeck (World Bank), and Richard Zeckhauser (Harvard University). References
  2. [8]8. Cropper M, Hammitt JK, Robinson LA. Valuing mortality risk reductions: progress and challenges. Resources for the Future Discussion Paper no. 11-10. http://papers.ssrn.com/sol3/papers. cfm?abstract_id=1788975 (accessed Oct 17, 2013).
  3. [27]27. Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, eds. Disease control priorities in developing countries,1st edn. New York: Oxford University Press, 1993.
  4. [28]28. Misra R. Disease control priorities in developing countries, second edition: perspective of a policymaker. 2006. http://www.dcp2.org/ main/ExpertEssays.html (accessed Oct 17, 2013).
  5. [29]29. Abbasi K. The World Bank on world health: under fi re. BMJ 1999; 318: 1003-06.
  6. [50]50. Commission on Health Research for Development. Health research: essential link to equity in development. Report of the Commission on Health Research for Development. New York, NY: Oxford University Press, 1990.
  7. [52]52. Moran M, Guzman J, Henderson K, et al. G-FINDER, 2012: neglected disease research and development: a fi ve year review. Sydney: Policy Cures, 2012.
  8. [65]65. Easterlin R. How benefi cent is the market? A look at the modern history of morality. Res Econ Hist 1999; 3: 257-94.
  9. [74]74. Walz J, Ramachandran V. Brave new world: a literature review of emerging donors and the changing nature of foreign assistance. Center for Global Development (CGD) Working Paper 273. 2011. http://www.cgdev.org/content/publications/detail/1425691 (accessed Oct 17, 2013).
  10. [78]78. Dybul M, Piot P, Frenk J. Reshaping global health. Hoover Institution Policy Review, no. 173, June 1, 2012. http://www. hoover.org/publications/policy-review/article/118116 (accessed May 7, 2013).
  11. [84]84. Feachem RGA, Kjellstrom T, Murray CJL, Over M, Phillips MA, eds. The health of adults in the developing world. New York: Oxford University Press, 1992.
  12. [85]85. Bobadilla JL, Frenk J, Lozano R, Frejka T, Stern C. The epidemiological transition and health priorities. In: Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, eds. Disease control priorities in developing countries, 1st edn. New York: Oxford University Press, 1993: 51-63.
  13. [87]87. WHO. Every woman, every child: strengthening equity and dignity through health. The second report of the independent Expert Review Group (iERG) on Information and Accountability for Women's and Children's Health. Geneva: World Health Organization, 2013.
  14. [106]106. Rosenzweig M, Stark O, eds. Handbook of population and family economics, vol 1A. Amsterdam: Elsevier, 1997: 483-81. 104
  15. [129]129. Chen L, Evans T, Anand S, et al. Human resources for health: overcoming the crisis. Lancet 2004; 364: 1984-90. 130
  16. [145]145. Pearson TA, Jamison DT, Trejo-Guttierez J. Cardiovascular disease. In: Jamison DT, Mosley WH, Meashem AR, Bobadilla JL, eds. Disease control priorities in developing countries, 1st edn. New York: Oxford University Press, 1993: 577-94. 155
  17. [171]171. Elbel B, Kersh R, Brescoll VL, Dixon LB. Calorie labeling and food choices: a fi rst look at the eff ects on low-income people in New York City. Health Aff 2009; 28: w1110-21. 186
  18. [175]175. Debas HT, Gosselin R, McCord C, Thind A. 2006. Surgery. In: Jamison DT, Breman JG, Measham AR, et al, eds. Disease control priorities in developing countries, 2nd edn. New York: Oxford University Press, 2006: 1245-59. 191
  19. [176]176. Norton R, Kobusingye O. Injuries. N Engl J Med 2013; 368: 1723-30. 192
  20. [190]190. Hernández-Torres J, Avila-Burgos L, Valencia-Mendoza A, Poblano-Verástegui O. [Seguro Popular's initial evaluation of household catastrophic health spending in Mexico]. Rev Salud Publica 2008; 10: 18-32 [in Spanish]. 212
  21. [205]205. Evans D. Contracting and health. Bull World Health Organ 2006; 84: 850-51. 229 House of Commons Health Committee. Commisssion. 2010. http://www.publications.parliament.uk/pa/cm200910/cmselect/ cmhealth/268/268i.pdf#page=10 (accessed Oct 17, 2013). 230
  22. [212]212. Feachem RGA, Sekhri NK, White KL. Getting more for their dollar: a comparison of the NHS with California's Kaiser Permanente. BMJ 2002; 324: 135-41. 238
  23. [222]222. Hecht R, Jamison DT. Vaccine research and development assessment paper. In: Lomborg B, ed. Rethink HIV: smarter ways to invest in ending HIV in sub-Saharan Africa. New York: Cambridge University Press, 2012: 299-320. 250

Cited by

Sorted by citations

Authors
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., Ghosh, G., Goldie, S. J., Guo, Y., Gupta, S., Horton, R., Kruk, M. E., Mahmoud, A., Mohohlo, L. K., Ncube, M., Pablos-Mendez, A., Reddy, K. S., Saxenian, H., Soucat, A., Ulltveit-Moe, K. H., & Yamey, G.
Affiliations
  • University of Washington (US)
  • Harvard University (US)
  • University of the West Indies (JM)
  • Stanford University (US)
  • Gavi (CH)
  • World Health Organization (CH)
  • University of California, San Francisco (US)
  • Gates Foundation (US)
  • Peking University (CN)
  • International Monetary Fund (US)
  • Columbia University (US)
  • Princeton University (US)
  • African Development Bank Group (CI)
  • Public Health Foundation of India (IN)
  • Results for Development Institute (US)
Corresponding author
Yamey, Gavin
Venue
The Lancet
Publisher
Elsevier BV
Published
2013-12
Volume
382
Issue
9908
Pages
1898-1955
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4320288076
Cited by
1,220
References
174
Citations by year
2026: 47 · 2025: 62 · 2024: 49 · 2023: 53 · 2022: 72 · 2021: 121 · 2020: 101 · 2019: 112 · 2018: 106 · 2017: 125 · 2016: 129 · 2015: 141 · 2014: 95 · 2013: 6
FWCI
215.66
Type
journal article
Language
en
Update notices
erratum (2014-01-18)
Open access
Licence
other-oa
Locations
  • The Lancet (publishedVersion, other-oa)
  • PubMed (publishedVersion)
Funders
  • Bill and Melinda Gates Foundation
  • World Bank Group
  • Harvard University
  • University of Washington
  • Harvard Global Health Institute
  • Department for International Development
  • Direktoratet for Utviklingssamarbeid
  • University of California, San Francisco
Topics
  • Social Sciences › Economics, Econometrics and Finance › Finance › Healthcare Systems and Reforms
  • Health Sciences › Health Professions › General Health Professions › Global Health Care Issues
  • Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
Keywords
global health, non-communicable diseases, injuries, universal health coverage, fiscal policy, tobacco taxation, fossil fuel subsidies, health system strengthening, health care financing, social determinants of health, health equity, financial protection, population-level interventions, child mortality, maternal mortality, infectious disease mortality
MeSH terms
Delivery of Health Care, Developing Countries, Health Expenditures, Humans, International Cooperation, Global Health, Universal Health Insurance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review